Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye. [Phase 2, Phase 3]

View source ↗

Summary

A clinical study evaluating the safety and efficacy of SI-614 ophthalmic solution in dry eye syndromes has completed Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndromes

Drugs mentioned

• SI-614 Ophthalmic Solution (SI-614)

Snippet

Sponsor: Seikagaku Corporation | Conditions: Dry Eye Syndromes | Phase 2, Phase 3 | Status: COMPLETED